Investor Relations

See Stock Info

Our Mission

At Delcath, we are dedicated to advancing liver-targeted therapies that improve survival and quality of life for patients with liver-dominant cancers. Through our Hepatic Delivery System (HDS), we strive to bring innovative treatments to patients worldwide, beginning with uveal melanoma and expanding into other cancer types. With a patient-centered focus, a commitment to scientific innovation, and a drive for global impact, we aim to transform liver cancer care while creating long-term value for our stakeholders.

Core Values

We believe in the power of teamwork across all levels of the organization, fostering mutual respect and collective ownership to drive innovative cancer therapies and deliver exceptional patient outcomes.
We put patients first, making decisions that prioritize their safety and well-being while actively engaging with healthcare professionals and stakeholders to ensure our treatments make a meaningful impact.
We are driven by a forward-thinking mindset, pioneering breakthrough therapies that revolutionize liver cancer treatment through our Hepatic Delivery System (HDS) platform.
We lead with a commitment to data-driven decision-making, ensuring that our actions not only deliver life-saving therapies for patients today but also pave the way for a sustainable future of continued innovation. By maintaining a strong foundation, we enable the development of groundbreaking therapies that will transform cancer care for years to come.
We uphold a culture of integrity and transparency, adhering to the highest regulatory and ethical standards in every aspect of our work.
We are committed to delivering life-saving results for patients, holding ourselves accountable to creating lasting value for all our stakeholders.

Press Releases

View all press releases

Corporate Presentation

Our corporate presentation offers a comprehensive overview of our innovative treatments, strategic vision, and financial performance. Discover how we are pioneering advanced oncology solutions and driving growth for a brighter future.

Events

Upcoming Events

More events are coming soon.

Past Events

View all presentations & events

Corporate Governance

Leadership

Our leadership team is dedicated to driving innovation and excellence in interventional oncology.

Learn more

Governance Docs

Access our comprehensive governance documents that outline our commitment to ethical and transparent business practices.

Learn more

Committee Composition

Explore the diverse expertise and roles within our committee composition that ensure robust corporate governance.

Learn more
Disclaimer

You are about to review presentations, reports, filings and/or other materials regarding Delcath Systems, Inc. (NASDAQ: DCTH) that contain time-sensitive information. The information contained therein is only current as of the date thereof. Delcath expressly disclaims any obligation to review, update or correct these materials after the date thereof. Delcath may update, amend, supplement or otherwise alter the information contained in any such materials by subsequent presentations, reports, filings, or other means without notice. Certain statements made on this Web site or in materials accessed in or through this section of our Web site are “forward–looking statements,” which are subject to risks and uncertainties, and Delcath’s actual results may differ (possibly materially) from those indicated in such statements. Data Provided by Thomson Reuters.